CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives Sleep quality and risk of coronary heart disease-a prospective cohort study from the English longitudinal study of ageing Cellular origin and developmental program of coronary angiogenesis Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial

Original Research2008 Jun;57(6):1702-6.

JOURNAL:Diabetes. Article Link

Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes

Costacou T, Ferrell RE, Orchard TJ. Keywords: T1DM; haptoglobin genotype; haptoglobin 2/2 genotype;

FULL TEXT PDF